Synthetic Biologist Aims to Create Pig with Human Lungs
By Lisa M. Krieger,
San Jose Mercury News
| 11. 14. 2014
Untitled Document
SAN FRANCISCO -- In a provocative cross-species experiment, scientists are striving to rewrite the pig genome so the animal grows lungs that could be transplanted into humans.
"We are re-engineering the pig, changing its genetic code," said genome pioneer Craig Venter at SynBioBeta 2014, an annual synthetic biology conference in San Francisco. "If we succeed with rewriting the pig genome, we will have replacement organs for those who need them," he said Friday.
His team at Synthetic Genomics is designing the project, he said, creating on computers the code needed to build the hybrid. By changing as few as five genes, they have created lungs that survived for a year in baboons, he said.
In other major news at the conference, Google confirmed that Stanford University bioengineer Drew Endy has joined its team at the secretive Google X, which created such projects as Google Glass, driverless cars and high-altitude Wi-Fi balloons.
The hiring of Endy, brought to Stanford's School of Engineering from the Massachusetts Institute of Technology, suggests that Google seeks to explore the design and construction of...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...